Follicular Dendritic Cell
Follicular dendritic cells (FDCs) are non-hematopoietic mesenchymal stromal cells residing in primary B-cell follicles and germinal center light zones that secrete CXCL13 and retain intact opsonized antigen-antibody immune complexes via CR1/CR2 and FcγRIIb to drive B-cell somatic hypermutation affinity selection.
Follicular dendritic cells (FDCs) are specialized, non-hematopoietic, mesenchymal stromal cells (CD45−CD31−PDPN+/−CR1/CD35highCR2/CD21highFcγRIIbhigh) that form a dense, interconnected three-dimensional reticular network within the primary B-cell follicles and the light zone of active germinal centers across all secondary lymphoid organs (lymph nodes, spleen, tonsils, and mucosal Peyer's patches) as well as tertiary lymphoid structures. Despite sharing a stellate ("dendritic") morphology with bone-marrow-derived conventional dendritic cells (cDCs), FDCs are not hematopoietic leukocytes, do not arise from bone marrow myeloid progenitors, lack phagocytic endolysosomal proteolysis and major histocompatibility complex class II (MHC-II) synthesis, and do not prime naive T cells. Instead, FDCs differentiate from local perivascular PDGFRβ+ precursors and subcapsular marginal reticular cells under the continuous trophic stimulation of B-cell-derived lymphotoxin-α1β2 (LTα1β2) and tumor necrosis factor-alpha (TNF-α). Mature FDCs organize the follicular B-cell compartment by secreting the chemokine CXCL13 and capturing intact, native antigen–antibody–complement immune complexes via complement receptors CR1 (CD35) and CR2 (CD21) and the low-affinity IgG receptor FcγRIIb (CD32b)—periodically recycling these native antigens through non-degradative endosomes for weeks to months so that somatically mutated B cells can test their B-cell receptor (BCR) affinity and compete for follicular helper T cell (TFH) survival signals.
Mesenchymal Origin and Lymphotoxin / TNF-α Stromal Crosstalk
Perivascular Mural Precursors and Marginal Reticular Cell Remodeling
First described histologically by Alexander Maximow (1927) as "embryonic reticular cells" and characterized ultrastructurally in the 1960s and 1970s by G. J. V. Nossal, Klaus Rajewsky, John G. Tew, and Ralph M. Steinman (who distinguished non-hematopoietic FDCs from bone-marrow-derived MHC-II+ conventional dendritic cells), FDCs are radiation-resistant CD45− mesenchymal stromal cells. Genetic lineage-tracing studies by Adriano Aguzzi and colleagues (2012) and Marc Bajénoff and Ronald N. Germain (2013) demonstrated that FDCs arise from two related local mesenchymal pools:
- Ubiquitous Perivascular Mural Cell Precursors (PDGFRβ+MFGE8+NG2+): During embryogenesis and neonatal lymphoid organogenesis, perivascular mural cells (pericyte-like precursors wrapping blood vessels) stimulated by lymphoid tissue inducer (LTi) cells and incoming B cells expand and differentiate into primary FDC networks inside nascent B-cell follicles.
- Adult Expansion from Marginal Reticular Cells (MRCs): During adult immunization or infection, when primary follicles expand rapidly into secondary germinal centers, marginal reticular cells (PDPN+MAdCAM-1+RANKL+CXCL13+) positioned directly beneath the lymph node subcapsular sinus proliferate and differentiate downward into the follicle to generate new light-zone FDCs.
Reciprocal Positive Feedback Loop: B-Cell LTα1β2 ↔ FDC CXCL13 & BAFF
Unlike fibroblastic reticular cells in the paracortical T-cell zone—which persist even if T cells are depleted—mature FDC networks require continuous contact-dependent signaling from B lymphocytes for both their development and their day-to-day maintenance:
- LTα1β2–LTβR and TNF-α–TNFR1 Signaling: Resting follicular B cells constitutively express membrane-bound heterotrimeric lymphotoxin-α1β2 (LTα1β2) alongside soluble and membrane TNF-α. Engagement of lymphotoxin-β receptor (LTβR) and TNFR1 (p55) on FDC precursors activates both the canonical NF-κB pathway (RelA–p50) and the non-canonical NF-κB pathway (NIK → IKKα → RelB–p52).
- The CXCL13–CXCR5 Positive Feedback Loop: As shown by Jason G. Cyster and colleagues (2000), LTβR/TNFR1 activation of RelB–p52 in FDCs drives high-level transcription and secretion of CXCL13 (BLC). Secreted CXCL13 binds CXCR5 on circulating B cells (and follicular helper T cells and follicular regulatory T cells), attracting B cells into the follicle and simultaneously upregulating B-cell surface LTα1β2 expression—creating a self-organizing positive feedback loop. If LTβR signaling is pharmacologically blocked with soluble LTβR-Ig fusion protein, FDC networks dedifferentiate and disappear within 48 to 72 hours, collapsing follicular structure and shedding trapped immune complexes.
| Stromal or Myeloid Cell Type | Lineage & Embryonic Origin | Anatomical Compartment | Signature Surface Markers | Primary Secreted Factors | Antigen Handling Mode |
|---|---|---|---|---|---|
| Follicular Dendritic Cell (FDC) | Mesenchymal (CD45−); from PDGFRβ+ pericytes & MRCs | B-cell follicle & Germinal Center Light Zone (LZ-FDC) or Dark Zone (DZ-FDC) | CD45− CD31− CD21/CD35hi FcγRIIbhi FDC-M1 (MFGE8)+ VCAM-1+ ICAM-1+ | CXCL13, BAFF, IL-6, IL-15, MFGE8, C4, soluble CD21 | Non-degradative recycling of native C3d/IgG immune complexes on iccosomes |
| Fibroblastic Reticular Cell (FRC) | Mesenchymal (CD45−); from LTo stromal progenitors | Paracortical T-cell zone & medullary cords | CD45− CD31− PDPN (gp38)+ PDGFRα/β+ ER-TR7+ | CCL19, CCL21, IL-7, type I/III collagen conduits, NO (iNOS) | Forms conduit network transporting <70 kDa soluble lymph antigens |
| Marginal Reticular Cell (MRC) | Mesenchymal (CD45−); adult FDC progenitor | Subcapsular sinus floor (outer follicular rim) | CD45− CD31− PDPN+ MAdCAM-1+ RANKL+ CXCL13+ | CXCL13, RANKL (TRANCE), CSF-1 (M-CSF), VEGF | Transports small antigens via conduits to FDCs; differentiates into FDCs |
| Subcapsular Sinus Macrophage (SCS Mφ) | Hematopoietic myeloid (CD45+); yolk sac / bone marrow | Floor of lymph node subcapsular sinus | CD45+ CD169 (Siglec-1)+ CD11b+ CR3+ F4/80− | IFN-α/β, IL-18, IL-1β, CCL2 | Captures lymph-borne viruses & immune complexes and translocates intact antigen to B cells |
| Conventional Dendritic Cell (cDC1 / cDC2) | Hematopoietic myeloid (CD45+); bone marrow Flt3+ CDP | Paracortical T-cell zone & interfollicular T–B border | CD45+ CD11chi MHC-IIhi CD80/CD86+ (XCR1+ or SIRPα+) | IL-12, IL-6, IL-23, CCL17, CCL22 | Endolysosomal proteolytic degradation into linear peptides loaded onto MHC-I / MHC-II |
Antigen Relay Pathways and Non-Degradative Endosomal Cycling
Three-Tiered Antigen Delivery to the FDC Network
Because the B-cell follicle and germinal center light zone are physically separated from afferent lymph and arterial blood by a tight stromal and macrophage barrier, intact antigens reach the FDC surface through three size- and opsonization-dependent relay mechanisms:
- Conduit Filtration of Small Soluble Antigens (<70 kDa): Low-molecular-weight proteins, toxins, and chemokines (<70 kDa; hydrodynamic radius <4–5 nm) arriving in afferent lymph enter B-cell follicle conduits formed by marginal reticular cells and FDCs, where FDC processes directly sample the conduit lumen.
- Subcapsular Sinus Macrophage → Non-Cognate Follicular B-Cell Relay (Lymph Nodes): Large viral particles, particulate vaccines, and C3b/C3d-coated immune complexes (>70 kDa) arriving in afferent lymph are captured on the luminal surface of CD169+ subcapsular sinus macrophages without being degraded. Non-cognate follicular B cells use their complement receptors (CR1/CR2) to pluck these complement-coated immune complexes off the basolateral tail of the subcapsular sinus macrophage, migrate into the follicle along the CXCL13 gradient, and hand the complex over to FDCs—which express 10- to 50-fold higher densities of CR1/CR2 than B cells, making the thermodynamic transfer from B cell to FDC unidirectional.
- Marginal Zone B-Cell S1PR1–CXCR5 Shuttling (Spleen): In the spleen, marginal zone B cells continuously cycle every ~2 hours between the blood-perfused marginal zone and the B-cell follicle, capturing blood-borne C3d-opsonized immune complexes and transferring them directly onto splenic FDCs.
Non-Degradative Cycling Endosomes and Beaded Iccosomes
Whereas macrophages and conventional dendritic cells internalize immune complexes into acidifying, cathepsin-rich phagolysosomes (pH 4.5–5.0) that digest native proteins into short linear peptides within minutes, FDCs preserve native three-dimensional conformational epitopes intact for months to years. Two-photon and super-resolution microscopy studies by Michael C. Carroll, Jason G. Cyster, and B. A. Heesters (2013) demonstrated why FDC-bound antigens resist proteolytic destruction:
- Periodic Cycling Through Non-Acidified Transferrin-Receptor+ Endosomes: When C3d/C3b-coated or IgG-coated immune complexes bind CR1 (CD35), CR2 (CD21), and FcγRIIb (CD32b) on the filiform dendrites of an FDC, the complexes are internalized into specialized non-degradative cycling endosomal compartments (pH ~6.0–6.5, lacking lysosomal proteases and LAMP-1) that periodically recycle back to the FDC plasma membrane. This intracellular shielding protects the native antigen from extracellular shear, oxidation, and stromal proteases while keeping it intermittently accessible on the FDC surface for centrocyte inspection.
- Iccosomes (Immune Complex-Coated Bodies): Along their dendritic processes, FDCs bud off 0.3- to 0.7-μm beaded membrane vesicles coated with concentrated antigen–antibody–complement complexes—termed iccosomes by John G. Tew and Andras K. Szakal (1988)—which germinal center B cells can endocytose whole to process and present peptide–MHC class II to TFH cells.
Biomechanical Force Discrimination in the Germinal Center Light Zone
Inside the mature germinal center, FDCs diversify into two spatially distinct subclusters identified by single-cell transcriptomics: Light-Zone FDCs (LZ-FDCs, CXCL13highCR1/CR2highFcγRIIbhighVCAM-1highICAM-1high) and Dark-Zone FDCs (DZ-FDCs / CXCL12-expressing reticular cells [CRCs], CXCL12highCXCR4-ligand+CR1/2low). After centroblasts undergo AID-driven somatic hypermutation in the CXCL12-rich dark zone, they migrate into the CXCL13-rich light zone as centrocytes and form integrin-stabilized (LFA-1–ICAM-1 and VLA-4–VCAM-1) contacts with LZ-FDCs.
As demonstrated by Pavel Tolar and colleagues (2013–2016) using live-cell force sensors, FDCs are mechanically stiff stromal cells:
- Actomyosin Pulling Force Test: Unlike soluble antigen (which activates high- and low-affinity B cells indiscriminately), antigen tethered tightly via multivalent C3d–CR2 and IgG–FcγRIIb bonds to the stiff FDC membrane requires the centrocyte to exert 10 to 50 piconewtons (pN) of actomyosin contractile pulling force through its BCR microclusters to physically rupture the FDC–antigen tether and extract the antigen. Low-affinity BCRs rupture before extracting the antigen, whereas high-affinity BCRs withstand the mechanical load, pinch off the antigen from the FDC, and present high densities of pMHC-II to win survival signals from follicular helper T cells (and evade suppression by follicular regulatory T cells).
- Antibody Feedback Masking and FcγRIIb Tuning: As high-affinity IgG antibodies accumulate in serum over the course of an immune response, newly secreted IgG enters the germinal center and binds epitopes on FDC-retained antigen, competitively masking low-affinity sites and cross-linking inhibitory FcγRIIb on B cells—progressively raising the affinity selection bar over weeks.
- Tingible Body Macrophage Licensing via MFGE8 (FDC-M1): Over 90% of germinal-center B cells fail affinity selection or suffer deleterious mutations and undergo apoptosis. FDCs secrete milk fat globule-EGF factor 8 (MFGE8, also known as the classical FDC marker FDC-M1), a bridging opsonin that binds phosphatidylserine on apoptotic centrocytes with one domain and engages αvβ3/αvβ5 integrins on tingible body macrophages with its RGD motif, ensuring rapid clearance of apoptotic B cells; deficiency of FDC-derived MFGE8 leaves unengulfed nuclear debris inside the germinal center and precipitates systemic lupus erythematosus.
Pathological Exploitation: HIV Reservoir and Neuroinvasive Prion Replication
Because the non-degradative endosomal cycling pathway of FDCs is engineered to preserve intact conformational proteins and virions for months without proteolysis, two classes of human pathogens hijack the FDC network as a protected anatomical sanctuary:
- Human Immunodeficiency Virus Type 1 (HIV-1) Extracellular Reservoir: Even during suppressive antiretroviral therapy (ART) that reduces plasma HIV-1 RNA below clinical detection limits, intact, replication-competent HIV-1 virions coated with C3d and non-neutralizing IgG remain trapped on CR2 (CD21) and FcγRIIb within the cycling endosomes of lymph node FDCs for months to years. As CD4+ TFH cells traffic continuously across the FDC network in the germinal center light zone, FDC-retained virions infect adjacent TFH cells in trans (an infection blockable experimentally by soluble CD21 decoy molecules or anti-CD21 cleavage).
- Transmissible Spongiform Encephalopathies (Prions): Following oral ingestion or peripheral exposure to infectious scrapie/variant Creutzfeldt-Jakob disease prions (PrPSc), FDCs express high endogenous levels of cellular prion protein (PrPC) and trap C1q/C3d-opsonized PrPSc aggregates on CR1/CR2. As proved by Adriano Aguzzi and Neil A. Mabbott, FDCs act as the obligatory peripheral amplification factory where PrPSc converts host PrPC before invading adjacent sympathetic nerve fibers to reach the central nervous system (neuroinvasion); transient depletion of FDCs with soluble LTβR-Ig prior to neuroinvasion completely prevents oral prion disease. Rarely, neoplastic transformation of FDCs themselves gives rise to follicular dendritic cell sarcoma (CD21+CD35+CD23+Clusterin+CXCL13+CD45−), an indolent mesenchymal tumor often associated with hyaline-vascular Castleman disease.
Frequently Asked Questions
Are follicular dendritic cells related to conventional bone-marrow-derived dendritic cells?
No. Despite both carrying "dendritic cell" in their names due to their branched, stellate cytoplasm, they belong to completely separate cellular lineages. Conventional dendritic cells (cDCs) are CD45+ hematopoietic myeloid leukocytes derived from bone marrow stem cells that phagocytose pathogens, degrade them into short linear peptides in lysosomes, and load those peptides onto MHC class I and II molecules to prime naive T cells. Follicular dendritic cells (FDCs) are CD45− non-hematopoietic mesenchymal stromal cells derived from local perivascular mural precursors and marginal reticular cells that do not phagocytose or degrade antigens, lack endogenous MHC-II synthesis, and instead display intact native antigen–antibody–complement complexes on their surface to select B cells in the germinal center.
How do follicular dendritic cells keep native antigens intact for months without digesting them?
When FDCs capture C3d- and IgG-coated immune complexes via CR1 (CD35), CR2 (CD21), and FcγRIIb, they internalize the complexes into specialized non-degradative cycling endosomes rather than acidic lysosomes. Unlike macrophage phagolysosomes (which acidify to pH 4.5 and contain high concentrations of cathepsin proteases), FDC cycling endosomes maintain a near-neutral pH (~6.0–6.5), lack proteolytic enzymes, and periodically recycle the intact immune complexes back to the cell surface, shielding conformational epitopes from extracellular degradation for months while presenting them to germinal center B cells.
Why does blocking lymphotoxin-β receptor (LTβR) signaling cause FDC networks to vanish?
Mature FDCs depend on continuous, contact-dependent lymphotoxin-α1β2 (LTα1β2) and TNF-α signals delivered by surrounding follicular B cells to maintain NF-κB (RelB–p52 and RelA–p50) transcription of CXCL13, CR1/CR2, and VCAM-1/ICAM-1. If this B-cell-to-FDC signal is interrupted by administering a soluble LTβR-Ig decoy receptor (or by depleting B cells), FDCs rapidly downregulate CR1/CR2 and CXCL13 within 48 to 72 hours, shedding their trapped immune complexes and collapsing the primary follicle and germinal center light zone.
References
- Cyster, J. G., Ansel, K. M., Reif, K., Ekland, E. H., Hyman, P. L., Tang, H. L., Luther, S. A., & Ngo, V. N. (2000). "Follicular stromal cells and lymphocyte homing to follicles." Immunological Reviews, 176, 181–193. https://doi.org/10.1034/j.1600-065X.2000.00618.x
- Krautler, N. J., Kana, V., Kranich, J., Tian, Y., Perera, D., Lemm, D., Schwarz, P., Armulik, A., Browning, J. L., Tallquist, M., Buch, T., Oliveira-Martins, J. B., Zhu, C., Ruddle, N. H., & Aguzzi, A. (2012). "Follicular dendritic cells emerge from ubiquitous perivascular precursors." Cell, 150(1), 194–206. https://doi.org/10.1016/j.cell.2012.05.032
- Heesters, B. A., Chatterjee, P., Kim, Y.-A., Gonzalez, S. F., Kuligowski, M. P., Kirchhausen, T., & Carroll, M. C. (2013). "Endocytosis and recycling of immune complexes by follicular dendritic cells enhances B cell antigen binding and activation." Immunity, 38(6), 1164–1175. https://doi.org/10.1016/j.immuni.2013.02.023
- Heesters, B. A., Myers, R. C., & Carroll, M. C. (2014). "Follicular dendritic cells: dynamic antigen libraries." Nature Reviews Immunology, 14(7), 495–504. https://doi.org/10.1038/nri3689